Virpax Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VRPX and buy or sell other stocks, ETFs, and their options commission-free!About VRPX
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray.
CEOGerald W. Bruce
CEOGerald W. Bruce
Employees7
Employees7
HeadquartersBerwyn, Pennsylvania
HeadquartersBerwyn, Pennsylvania
Founded2016
Founded2016
Employees7
Employees7
VRPX Key Statistics
Market cap7.84M
Market cap7.84M
Price-Earnings ratio-2.63
Price-Earnings ratio-2.63
Dividend yield—
Dividend yield—
Average volume108.34K
Average volume108.34K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.18
52 Week high$1.18
52 Week low$0.2402
52 Week low$0.2402
Stock Snapshot
With a market cap of 7.84M, Virpax Pharmaceuticals(VRPX) trades at $0.67. The stock has a price-to-earnings ratio of -2.63.
Virpax Pharmaceuticals(VRPX) stock opened on 2025-11-07 at —. The price climbed to — and dipped to —.
The Virpax Pharmaceuticals(VRPX)'s current trading volume is 0, compared to an average daily volume of 108.34K.
During the past year, Virpax Pharmaceuticals(VRPX) stock moved between $0.24 at its lowest and $1.18 at its peak.
During the past year, Virpax Pharmaceuticals(VRPX) stock moved between $0.24 at its lowest and $1.18 at its peak.
People also own
Based on the portfolios of people who own VRPX. This list is generated using Robinhood data, and it’s not a recommendation.